Page last updated: 2024-09-05

tbc-11251 and enkephalin, d-penicillamine (2,5)-

tbc-11251 has been researched along with enkephalin, d-penicillamine (2,5)- in 1 studies

Compound Research Comparison

Studies
(tbc-11251)
Trials
(tbc-11251)
Recent Studies (post-2010)
(tbc-11251)
Studies
(enkephalin, d-penicillamine (2,5)-)
Trials
(enkephalin, d-penicillamine (2,5)-)
Recent Studies (post-2010) (enkephalin, d-penicillamine (2,5)-)
16732581,314073

Protein Interaction Comparison

ProteinTaxonomytbc-11251 (IC50)enkephalin, d-penicillamine (2,5)- (IC50)
Mu-type opioid receptorHomo sapiens (human)0.0016
Delta-type opioid receptorHomo sapiens (human)0.0011

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brouwer, K; Gorczynski, R; Hartman, JC; Mandagere, A; Melvin, L1

Other Studies

1 other study(ies) available for tbc-11251 and enkephalin, d-penicillamine (2,5)-

ArticleYear
Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes.
    Canadian journal of physiology and pharmacology, 2010, Volume: 88, Issue:6

    Topics: Adolescent; Adult; Aged; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Bosentan; Cell Culture Techniques; Cells, Cultured; Endothelin Receptor Antagonists; Enkephalin, D-Penicillamine (2,5)-; Estradiol; Female; Hepatocytes; Humans; Isoxazoles; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Organic Anion Transporters; Organic Anion Transporters, Sodium-Dependent; Phenylpropionates; Pyridazines; Pyrimidines; Sulfonamides; Symporters; Taurocholic Acid; Thiophenes; Young Adult

2010